Pesquisar | Dugmont

Vikas Kokate compartilhou um link
2025-11-05 13:02:40 -

https://www.databridgemarketresearch.com/reports/global-dual-gip-glp-1-receptor-agonists-obesity

https://www.databridgemarketresearch.com/reports/global-dual-gip-glp-1-receptor-agonists-obesity

Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market – Global Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032 | Data Bridge Market Research
The Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs market was valued at USD 4.75 Billion in 2024 and is expected to reach USD 17.71 Billion by 2032, growing at a CAGR of 17.85% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.

0 Comentários 0 Compartilhamentos 41 Visualizações

Faça o login para curtir, compartilhar e comentar!
Vikas Kokate compartilhou um link
2025-11-04 13:17:30 -

https://www.databridgemarketresearch.com/reports/global-dual-gip-glp-1-receptor-agonists-obesity

https://www.databridgemarketresearch.com/reports/global-dual-gip-glp-1-receptor-agonists-obesity

Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market – Global Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032 | Data Bridge Market Research
The Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs market was valued at USD 4.75 Billion in 2024 and is expected to reach USD 17.71 Billion by 2032, growing at a CAGR of 17.85% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.

0 Comentários 0 Compartilhamentos 46 Visualizações

Faça o login para curtir, compartilhar e comentar!
Vikas Kokate compartilhou um link
2025-08-28 14:38:05 -

https://www.databridgemarketresearch.com/reports/global-dual-gip-glp-1-receptor-agonists-obesity

https://www.databridgemarketresearch.com/reports/global-dual-gip-glp-1-receptor-agonists-obesity

Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market – Global Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032 | Data Bridge Market Research
The Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs market was valued at USD 4.75 Billion in 2024 and is expected to reach USD 17.71 Billion by 2032, growing at a CAGR of 17.85% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.

0 Comentários 0 Compartilhamentos 180 Visualizações

Faça o login para curtir, compartilhar e comentar!